Ohio
Requires Coverage of Comprehensive Biomarker Testing
No
Highlighted Disparity
Asian or Pacific Islander individuals in Ohio are least likely to be diagnosed early
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases in Ohio is 63.9 and significantly higher than the national rate of 52.8.
 - It ranks 43rd among all states, placing it in the below average tier.
 - Over the last five years, the rate of new cases in Ohio improved by 12%.
 - In 2022, the most recent year of data available for this report, the COVID-19 pandemic continued to disrupt access to medical care, including delays and reductions in cancer diagnoses and screening. This led to a decline in incidence rates for most cancers, including lung cancer, and should not be interpreted as a reduction in the underlying cancer burden.
 
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer (the survival rate) in Ohio is 28.4%, which is significantly lower than the national rate of 29.7%.
 - It ranks 23rd among the 39 states with survival data, placing it in the average tier.
 - Over the last five years, the survival rate in Ohio improved by 29%.
 
Early Diagnosis:
- In Ohio, 29.2% of cases are caught at an early stage, which is significantly higher than the national rate of 28.1%.
 - It ranks 19th among the 50 states with data on diagnosis at an early stage, placing it in the average tier.
 - Over the last five years, the early diagnosis rate in Ohio improved by 19%.
 
Lung Cancer Treatment
Biomarker Coverage:
- Ohio has yet to require any insurance coverage of comprehensive biomarker testing, including for lung cancer, as of August 2025.
 
Surgical Treatment:
- Ohio ranked 22nd (out of the 49 states with available data) with 20.3% of cases undergoing surgery as part of the first course of treatment.
 - This is not significantly different than the national rate of 20.7% and puts Ohio in the average tier.
 - Over the last five years, the percent of cases undergoing surgery in Ohio did not change significantly.
 
No Treatment:
- Ohio ranked 6th (out of the 49 states with available data) with 16.2% of cases not receiving any treatment.
 - This is significantly lower than the national rate of 21.0% and puts Ohio in the top tier.
 - Over the last five years, the percent of cases receiving no treatment in Ohio did not change significantly.
 
Screening
Screening for High Risk:
- In Ohio, 19.2% of those at high risk were screened, which was not significantly different than the national rate of 18.2%.
 - It ranks 20th among all states, placing it in the average tier.
 - Screening rates in this year’s report have been updated to correct an error in the data source and should not be compared to previous reports.
 
Prevention
Tobacco Use:
- The 2023 smoking rate in Ohio is 15.0% and significantly higher than the national rate of 11.4%.
 - It ranks 41st among all states, placing it in the below average tier.
 
Radon Exposure:
- In Ohio, 48.8% of radon test results were at or above the action level recommended by EPA.
 - It ranks 47th among all states, placing it in the bottom tier.
 
Racial & Ethnic Disparities
Black individuals:
- The rate of new lung cancer cases is 66.6 per 100,000 population among Black individuals in Ohio, significantly higher than the rate of 54.2 among Black individuals nationally, and not significantly different than the rate of 64.9 among white individuals in Ohio.
 - The five-year survival rate is 29.8% among Black individuals in Ohio, significantly higher than the rate of 27.1% among Black individuals nationally, and not significantly different than the rate of 28.2% among white individuals in Ohio.
 - 29.0% of lung cancer cases are diagnosed at an early stage among Black individuals in Ohio, significantly higher than the rate of 25.1% among Black individuals nationally, and not significantly different than the rate of 29.3% among white individuals in Ohio.
 - 19.4% of Black individuals with lung cancer in Ohio underwent surgery, significantly higher than the rate of 17.1% among Black individuals nationally, and significantly lower than the rate of 20.4% among white individuals in Ohio.
 - 17.3% of Black individuals with lung cancer in Ohio did not receive any treatment, significantly lower than the rate of 22.7% among Black individuals nationally, and significantly higher than the rate of 16.1% among white individuals in Ohio.
 
Latino individuals:
- The rate of new lung cancer cases is 25.5 per 100,000 population among Latino individuals in Ohio, not significantly different than the rate of 27.9 among Latino individuals nationally, and significantly lower than the rate of 64.9 among white individuals in Ohio.
 - State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
 - 25.7% of lung cancer cases are diagnosed at an early stage among Latino individuals in Ohio, not significantly different than the rate of 23.9% among Latino individuals nationally, and not significantly different than the rate of 29.3% among white individuals in Ohio.
 - 20.7% of Latino individuals with lung cancer in Ohio underwent surgery, not significantly different than the rate of 21.4% among Latino individuals nationally, and not significantly different than the rate of 20.4% among white individuals in Ohio.
 - 18.8% of Latino individuals with lung cancer in Ohio did not receive any treatment, significantly lower than the rate of 25.8% among Latino individuals nationally, and not significantly different than the rate of 16.1% among white individuals in Ohio.
 
Asian or Pacific Islander individuals:
- The rate of new lung cancer cases is 30.5 per 100,000 population among Asian or Pacific Islanders individuals in Ohio, not significantly different than the rate of 32.5 among Asian or Pacific Islanders individuals nationally, and significantly lower than the rate of 64.9 among white individuals in Ohio.
 - State-level survival rates are not available for Asian or Pacific Islander individuals at this time. Nationally, the five-year survival rate among Asian or Pacific Islander individuals is 28.6% and significantly higher than the rate of 25.0% among white individuals.
 - 23.3% of lung cancer cases are diagnosed at an early stage among Asian or Pacific Islander individuals in Ohio, not significantly different than the rate of 23.7% among Asian or Pacific Islander individuals nationally, and significantly lower than the rate of 29.3% among white individuals in Ohio.
 - 22.7% of Asian or Pacific Islander individuals with lung cancer in Ohio underwent surgery, not significantly different than the rate of 24.7% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 20.4% among white individuals in Ohio.
 - 14.4% of Asian or Pacific Islander individuals with lung cancer in Ohio did not receive any treatment, significantly lower than the rate of 19.8% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 16.1% among white individuals in Ohio.
 
Indigenous Peoples:
- The rate of new lung cancer cases is 19.5 per 100,000 population among Indigenous peoples (American Indians/Alaska Natives) in Ohio, significantly lower than the rate of 39.8 among Indigenous Peoples nationally, and significantly lower than the rate of 64.9 among white individuals in Ohio.
 - State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 22.3% and not significantly different than the rate of 25.0% among white individuals.
 - Other lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in Ohio due to too few cases over the time period to allow for accurate analysis.
 
Summary
Despite the early diagnosis rate in Ohio falling into the average tier, the state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
Ohio has yet to require any insurance coverage of comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
Ohio falls into the top tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.
Page last updated: October 29, 2025
